Manage levodopa-induced motor complications in patients with Parkinson's disease with careful selection of other antiparkinsonian agents

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.1, 2008-01, pp. : 17-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson's Disease

By Jankovic Joseph  

CNS Drugs, Vol. 21, Iss. 8, 2007-01 ,pp. : 677-692

Adis International

Access to resources Recommend Favorite

Levodopa-Induced Response Fluctuations in Patients with Parkinson’s Disease: Strategies for Management

By van Laar T.  

CNS Drugs, Vol. 17, Iss. 7, 2003-01 ,pp. : 475-489

Adis International

Access to resources Recommend Favorite

Motor complications, levodopa metabolism and progression of Parkinson's disease

By Müüller Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite

Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinson's Disease

By Antonini Angelo  

CNS Drugs, Vol. 24, Iss. 2, 2010-02 ,pp. : 119-129

Adis International

Access to resources Recommend Favorite

Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's disease

By Müller Thomas  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 6, 2013-06 ,pp. : 707-718

Informa Healthcare

Access to resources Recommend Favorite